Publisher
Springer Science and Business Media LLC
Reference146 articles.
1. Flanigan, R. C. & Yonover, P. M. The role of radical nephrectomy in metastatic renal cell carcinoma. Semin. Urol. Oncol. 19, 98–102 (2001).
2. Bosse, D. & Ong, M. Evolution in upfront treatment strategies for metastatic RCC. Nat. Rev. Urol. 17, 73–74 (2020).
3. Siegel, R. L., Miller, K. D., Fuchs, H. E. & Jemal, A. Cancer statistics, 2022. CA Cancer J. Clin. 72, 7–33 (2022).
4. Flanigan, R. C. et al. Nephrectomy followed by interferon α-2b compared with interferon α-2b alone for metastatic renal-cell cancer. N. Engl. J. Med. 345, 1655–1659 (2001).
5. Mickisch, G. H. et al. Radical nephrectomy plus interferon-α-based immunotherapy compared with interferon α alone in metastatic renal-cell carcinoma: a randomised trial. Lancet 358, 966–970 (2001).